Cancer cell proliferation suppression agent and composition for suppressing proliferation of cancer cells
A technology for inhibiting proliferation and cancer cells, applied in drug combinations, skin care preparations, anti-toxic agents, etc., can solve problems such as inability to protect cells
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0127] In one embodiment, the present invention provides a method for inhibiting proliferation of cancer cells, which includes the step of administering to a mammal an inositol derivative obtained by binding sugar (monosaccharide or oligosaccharide) to inositol. The aforementioned cancer cell growth is preferably cancer cell growth promoted by air pollutants.
[0128] In one embodiment, the present invention provides a method for inhibiting cancer cell invasion, which includes the step of administering to a mammal an inositol derivative obtained by binding sugar (monosaccharide or oligosaccharide) to inositol. The aforementioned cancer cell infiltration is preferably cancer cell infiltration promoted by air pollutants.
[0129] In one embodiment, the present invention provides a method for inhibiting the expression of at least one gene selected from the group consisting of CYP1A1 gene, CYP1B1 gene, and ARNT gene, which comprises combining sugar (monosaccharide or oligosacchari...
Embodiment
[0160] Hereinafter, although an Example demonstrates this invention, this invention is not limited to a following Example.
manufacture example
[0162] Myo-inositol and β-cyclodextrin were reacted in the presence of cyclodextrin glucosyltransferase to produce an inositol derivative in which glucose or an oligosaccharide having glucose as a monosaccharide unit was bound to myo-inositol. As a result of analyzing the prepared myo-inositol derivatives by liquid chromatography-mass spectrometry (LC-MS), the ratio of molecules with one glucose chain bound to the glucose chain of myo-inositol was 12% by mass. The ratio of molecules with 2 glucose in the glucose chain of myo-inositol is 30% by mass, and the ratio of molecules with 3 glucose in the glucose chain of myo-inositol is 9% by mass. The proportion of molecules having 4 glucose chains in the glucose chain of the glycosaminoglycan was 12% by mass, and the proportion of molecules having 5 glucose chains bound to the glucose chain of myo-inositol was 2% by mass.
[0163] In the following experimental examples, the inositol derivatives produced in this production example w...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com